Pressure Ulcer Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Pressure Ulcer Treatment Market

The Pressure Ulcer Treatment market was valued at USD 6.69 billion in 2023, and the market is now projected tgrow tUSD 16.79 billion by 2032, exhibiting a CAGR of 6.8% during the forecast period of 2024-2032.

The surge in COVID-19 cases driven ta better number of patients requiring delayed clinic remains and mechanical ventilation. Outstandingly, the utilize of inclined situating tprogress respiratory work in serious cases expanded the chance of pressure ulcers, especially on the confront and other front body parts. This rise in weight ulcer cases among COVID-19 patients increased the request for treatment arrangements. The widespread alsintroduced challenges, counting disturbances within the supply chain and the reallocation of healthcare assets toversee COVID-19 cases, which at first moderated the pressure ulcer treatment market growth.

Pressure ulcer is one of the costliest and physically weakening complications within the 20th century. Different variables such as progressing age, inactive way of life, portability issues, and different wellbeing conditions have been mindful for expanding the predominance of pressure ulcers. Concurring ta piece of distributed by NCBI, a predominance of 12.7% in Brazil, 10.4% in Turkey, and 16% in Ethiopia were detailed for pressure ulcers in 2018. These patterns are showing a huge understanding pool seeking treatment. This, together with the expanding mindfulness among the quiet populace almost the accessibility of treatment and rise in healthcare use, particularly within the rising nations are expected tadvance expand the worldwide market development amid the estimate period.

The market is likely tbe moved by components, such as a significant rise within the geriatric populace living with incapacities, a quickly expanding predominance of pressure ulcers, and the developing selection of novel wound care gadgets for its treatment. The expanding mindfulness approximately the accessibility of treatment alternatives for PU, the rise in healthcare consumptions, and an increase in progressed treatment strategies are expected timpel the pressure ulcer treatment market development amid the estimate period. Combined with this, a rise within the request for multiple treatment choices by patients analysed around the globe is likely textend the pressure ulcer market measure amid the figure period.

Comprehensive Analysis of Pressure Ulcer Treatment Market

The ulcers types in the analysis of pressure ulcer treatment market are being categorized as stage 1, stage 2, stage 3 and stage 4. With the higher treatment costs in comparison tvarious other stages, the stage 4 is considered tbe the dominant one. Wound care devices and wound care dressing are the twcategories of the product type analysis. The four sorts of the pressure ulcer treatment are further categorized as home care settings, hospitals, clinics and ambulatory surgical centres.

North America with a revenue of over USD 2.75 billion accounted for the biggest pressure ulcer treatment market share within the projected period. Usually inferable tthe expanding predominance of weight ulcers, progressed healthcare offices, expanding modern dispatches of progressed innovations, and the higher cost of items in this region. The rising geriatric populace and expanding predominance of pressure ulcers are expected tdrive the market in this region.

The market for the Pressure Ulcer Treatment is majorly comprised of the conspicuous players that are working with great zeal within the market, demonstrating their presence and productive incomes with the broad investigate and imaginative hones and item advancement. Mölnlycke Health Care AB (Sweden), ConvaTec Group Plc (U.K.), B. Braun Melsungen AG (Germany), Coloplast Corp (Denmark), Smith & Nephew (U.K.), 3M (U.S.), Integra LifeSciences Corporation (U.S.), Cardinal Health (U.S.) and Tissue Regenix (U.K.) are the market players dedicatedly working towards the seriously investigate and advancement of the development in manufacturing and propelling Pressure Ulcer Treatment items enhanced with more wellbeing benefits and greatest supplement retention.

In the month of April 2020, AxioBiosolutions has declared the dispatch of MaxioCel, another generation wound care dressing made of chitosan, tbe utilized for the treatment of pressure ulcers. The item is considered tgive a 360-degree care with its torment administration, hemostatic, torment, and scar enhancement properties.

SEGMENTATION TABLE

ATTRIBUTE DETAILS

Study Period 2015-2026

Base Year 2018

Forecast Period 2019-2026

Historical Period 2015-2017

Unit Value (USD Billion)

By Ulcer Type

Stage 1

Stage 2

Stage 3

Stage 4

Segmentation By Product Type

Wound-care Dressings

Antimicrobial Dressing

Foam Dressings

Film Dressings

Alginate Dressings

Hydrocolloid Dressings

Other Dressings

Wound-care Devices

Others

By End User

Hospitals

Clinics

Ambulatory Surgical Centers

Homecare Settings

By Geography

North America (the U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

Latin America (Brazil, Mexico, and the Rest of Latin America)

Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)